ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 727,80
0,81%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Renovaro Inc (RENB)

  7. Renovaro Inc (RENB) Actualités

RENB

Renovaro (RENB)

Renovaro Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RENB
DateHeureSourceTitreSymboleSociété
14/06/202415h06GlobeNewswire Inc.Renovaro, Inc. Announces $10 million in Equity CommittedNASDAQ:RENBRenovaro Inc
11/06/202417h29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RENBRenovaro Inc
31/05/202403h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RENBRenovaro Inc
24/05/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RENBRenovaro Inc
24/05/202415h20GlobeNewswire Inc.Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer ImmunotherapyNASDAQ:RENBRenovaro Inc
18/05/202403h37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RENBRenovaro Inc
30/04/202417h00GlobeNewswire Inc.Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on FragmentomicsNASDAQ:RENBRenovaro Inc
24/04/202415h00GlobeNewswire Inc.RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics PartnershipNASDAQ:RENBRenovaro Inc
18/04/202414h45GlobeNewswire Inc.Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient CaNASDAQ:RENBRenovaro Inc
23/02/202423h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RENBRenovaro Inc
23/02/202422h04Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RENBRenovaro Inc
22/02/202422h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RENBRenovaro Inc
15/02/202415h25GlobeNewswire Inc.Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplaceNASDAQ:RENBRenovaro Inc
14/02/202416h01GlobeNewswire Inc.Statement of Renovaro IncNASDAQ:RENBRenovaro Inc
13/02/202415h31GlobeNewswire Inc.AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized MedicineNASDAQ:RENBRenovaro Inc
25/01/202418h45GlobeNewswire Inc.Renovaro Biosciences Announces Results of Special Meeting of ShareholdersNASDAQ:RENBRenovaro Inc
16/01/202414h00GlobeNewswire Inc.Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MDNASDAQ:RENBRenovaro Inc
11/10/202315h25GlobeNewswire Inc.Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of DirectorsNASDAQ:RENBRenovaro Inc
10/10/202314h00GlobeNewswire Inc.Renovaro Biosciences Appoints Two Finance Industry Experts to Board of DirectorsNASDAQ:RENBRenovaro Inc
06/10/202322h30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RENBRenovaro Inc
04/10/202322h20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RENBRenovaro Inc
02/10/202318h05GlobeNewswire Inc.Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MDNASDAQ:RENBRenovaro Inc
02/10/202315h28Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RENBRenovaro Inc
02/10/202315h25GlobeNewswire Inc.AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to CombineNASDAQ:RENBRenovaro Inc
02/10/202313h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RENBRenovaro Inc
30/09/202309h32Business WireGEDi Cube und Renovaro Biosciences unterzeichnen endgültige FusionsvereinbarungNASDAQ:RENBRenovaro Inc
30/09/202309h32Business WireGEDi Cube e Renovaro Biosciences siglano un accordo definitivo per realizzare una business combinationNASDAQ:RENBRenovaro Inc
29/09/202323h00Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:RENBRenovaro Inc
29/09/202319h36Business WireGEDi Cube et Renovaro Biosciences signent un accord définitif de fusionNASDAQ:RENBRenovaro Inc
29/09/202315h15GlobeNewswire Inc.Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to CombineNASDAQ:RENBRenovaro Inc
 Showing the most relevant articles for your search:NASDAQ:RENB

Dernières Valeurs Consultées

EU
ML
Michelin
EU
CS
Axa
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
EU
VIV
Vivendi
EU
LR
Legrand
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
JPM
JP Morgan Chase
EU
PX1
CAC 40
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés